Inclusion Criteria:  Patients have to be 18 years or older Newly diagnosed nAMD (group 1) or nAMD treatment for at least 1 year (group 2), both with typical neovascular findings on OCT-A Patients with acceptable travel distance to the hospital Patients accepting to be part of the study  Exclusion Criteria:  Other non-AMD macular disorders A spherical equivalent of -6 diopters or less Opacities of the visual axis; Changes of the cornea, anterior chamber, lens or vitreous cavity causing image acquisition artefacts Patients not able to attend extra controls due to age, illnesses or other factors Contraindications of intraocular injection therapy; Active ocular or periocular infection, active and serious intraocular inflammation, hypersensitivity to the drug or recent stroke / heart attack